Page last updated: 2024-12-10

undecaprenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

undecaprenol: a C55 terpene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

all-trans-undecaprenol : A long-chain primary fatty alcohol that is the all-trans-isomer of undecaprenol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280474
CHEBI ID16591
SCHEMBL ID788109
MeSH IDM0068824

Synonyms (18)

Synonym
26296-50-4
(2e,6e,10e,14e,18e,22e,26e,30e,34e,38e)-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-ol
CHEBI:16591
undecaprenol
all-trans-undecaprenol
15575-14-1
3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaen-1-ol
LMPR03010007
3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2e,6e,10e,14e,18e,22e,26e,30e,34e,38e,42-undecaen-1-ol
50426-50-1
ficaprenol
3,7,11,15,19,23,27,31,35,39,43-undecamethyl-2,6,10,14,18,22,26,30,34,38,42-tetratetracontaun cecaen-1-ol
TXKJNHBRVLCYFX-RDQGWRCRSA-N
SCHEMBL788109
Q27101987
undecaprenol from ailanthus altissima
moraprenol 11
ficaprel 11

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
undecaprenolsPolyprenols comprising eleven prenyl units with a terminal hydroxy group.
long-chain primary fatty alcoholA long-chain fatty alcohol in which the hydroxy group is attached to a methylene (CH2) group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (38.10)18.7374
1990's3 (14.29)18.2507
2000's4 (19.05)29.6817
2010's4 (19.05)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 27.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index27.21 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (27.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]